ArticleRadiology case reports2026
The pseudocirrhotic liver: Hepar lobatum carcinomatosum in a patient with triple-negative breast cancer.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepar lobatum carcinomatosum (HLC) is a rare hepatic manifestation of metastatic malignancy that mimics cirrhosis in imaging and morphology but arises from entirely different pathophysiological mechanisms. Most commonly associated with breast cancer, particularly hormone-receptor-positive subtypes, HLC in the context of triple-negative breast cancer is extremely rare. This report presents the case of a 65-year-old woman with triple-negative breast cancer who developed progressive liver deformation consistent with HLC over a 12-month period, as documented by sequential computed tomography and Magnetic resonance imaging. Despite systemic chemotherapy, the liver showed marked lobulation, capsular retraction, and segmental atrophy in the absence of cirrhosis risk factors. Radiological features and clinical findings were analysed in light of current literature. The case emphasizes the need for heightened clinical suspicion and diagnostic accuracy to distinguish HLC from pseudocirrhosis and true cirrhosis, thereby improving patient management and prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.